Why would a firm invest in research improving Super-Rare-Disease therapies if I don't get exclusive rights to the monetary benefit?
And to the inevitable room temperature IQ DSA crowd, why would the ML government with state research firms ever direct public resources to improving Super-Rare-Disease? Something that affects 1-in-10000 people doesn't deserve public resources like common diseases.
s/ancap/marxist leninist/